Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Nutrition foundations
Research brief

Luteolin in fruit flies: adult female benefits, embryonic lifespan harm

In Drosophila, luteolin given to adult females was linked to an 11.6% higher median lifespan and better movement and stress resistance, while embryonic exposure shortened lifespan; males responded little. These are fly findings, not human outcomes. [1]

Automatic summary · not editorially reviewed

The key findings

  1. Fruit flies were exposed to luteolin either during adulthood or during embryonic development, then assessed for lifespan, healthspan, metabolic regulation and aging-related molecular changes. [1]

  2. Adult supplementation increased median lifespan by 11.6% and improved locomotor activity and stress resistance, with pronounced female-specific benefits and little response in males. [1]

  3. Embryonic exposure shortened lifespan and disrupted endocrine and metabolic homeostasis, with elevated juvenile hormone levels, reduced catalase activity and dysregulated IIS signaling. [1]

The source at a glance

Study type / format
Experimental study in Drosophila (abstract)
Population / context
Drosophila melanogaster fruit flies exposed to luteolin in adulthood or during embryonic development
Summary based on
Study abstract
Original publication
August 20, 2026

Luteolin timing and sex in fruit flies

The study exposed Drosophila melanogaster to the dietary flavonoid luteolin either during adulthood or during embryonic development. It then assessed lifespan, healthspan, metabolic regulation and aging-related molecular changes. The authors state that effects of luteolin on physiological aging, and the role of developmental stage and biological sex, were previously poorly understood.

Supporting source [1]

Female-specific adult benefits in the abstract

Adult supplementation showed pronounced benefits specific to females: median lifespan rose by 11.6%, locomotor activity and stress resistance improved, and body weight changed little. Males showed little response. Short-term supplementation in early adulthood was reported to produce sustained protective effects later in life. Mechanistically, the abstract lists enhanced antioxidant defenses, suppressed IIS/PI3K-mTOR signaling, activated AMPK/MAPK pathways, promoted autophagy and immune homeostasis, and metabolic remodeling with reduced mitochondrial stress and favorable histone modifications.

Supporting source [1]

Embryonic exposure shortened lifespan in the abstract

In contrast, embryonic exposure shortened lifespan and disrupted endocrine and metabolic homeostasis, with elevated juvenile hormone levels, reduced catalase activity and dysregulated IIS signaling. The authors conclude that luteolin's effects on aging in Drosophila depend strongly on developmental stage and biological sex, and that developmental exposure produced adverse outcomes.

Supporting source [1]

How to interpret this

This is an abstract; the full text was not reviewed. All findings come from Drosophila melanogaster, not humans, and describe associations and proposed mechanisms rather than proven causes or human lifespan benefits.

Based on the study abstract; the full paper, tables and supplementary data were not reviewed.

Source & supporting passages

[1]
Luteolin promotes healthy aging in adult females but shortens lifespan after embryonic exposure in <i>Drosophila melanogaster</i>.

Wu Q, Ouyang B, Cao H, Zhang M, Farag MA, Efferth T, Simal-Gandara J, Xiao J. · europepmc.org · August 20, 2026

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    exposed to luteolin during either adulthood or
  2. Finding 2 ↑

    increasing median lifespan by 11.6%
  3. Finding 3 ↑

    embryonic exposure shortened lifespan and disrupted endocrine

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…